These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32536446)

  • 21. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
    Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
    Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain Dynamics and Temporal Summation of Pain Predicts Neuropathic Pain Relief from Ketamine Infusion.
    Bosma RL; Cheng JC; Rogachov A; Kim JA; Hemington KS; Osborne NR; Venkat Raghavan L; Bhatia A; Davis KD
    Anesthesiology; 2018 Nov; 129(5):1015-1024. PubMed ID: 30199420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain.
    Niesters M; Dahan A
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1409-17. PubMed ID: 22871026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of antinociceptive effect of ketamine in acute and neuropathic pain models in rats.
    Doncheva ND; Vasileva L; Saracheva K; Dimitrova D; Getova D
    Adv Clin Exp Med; 2019 May; 28(5):573-579. PubMed ID: 30561175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Side effects of ketamine in the long-term treatment of neuropathic pain.
    Cvrcek P
    Pain Med; 2008 Mar; 9(2):253-7. PubMed ID: 18298710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial.
    Delage N; Morel V; Picard P; Marcaillou F; Pereira B; Pickering G
    Trials; 2017 Nov; 18(1):517. PubMed ID: 29100524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain.
    Kvarnström A; Karlsten R; Quiding H; Emanuelsson BM; Gordh T
    Acta Anaesthesiol Scand; 2003 Aug; 47(7):868-77. PubMed ID: 12859309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current trends in neuropathic pain treatments with special reference to fibromyalgia.
    Offenbaecher M; Ackenheil M
    CNS Spectr; 2005 Apr; 10(4):285-97. PubMed ID: 15902759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidence.
    Granot R; Day RO; Cohen ML; Murnion B; Garrick R
    Pain Med; 2007; 8(1):48-64. PubMed ID: 17244104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ketamine in the therapy of chronic pain and depression].
    Jaksch W; Likar R; Aigner M
    Wien Med Wochenschr; 2019 Nov; 169(15-16):367-376. PubMed ID: 30980201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients.
    Kannan TR; Saxena A; Bhatnagar S; Barry A
    J Pain Symptom Manage; 2002 Jan; 23(1):60-5. PubMed ID: 11779670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidation of pathophysiology and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm.
    Anghelescu DL; Tesney JM
    Paediatr Drugs; 2019 Apr; 21(2):59-70. PubMed ID: 30761460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based pharmacological treatment of neuropathic pain syndromes.
    Beniczky S; Tajti J; Tímea Varga E; Vécsei L
    J Neural Transm (Vienna); 2005 Jun; 112(6):735-49. PubMed ID: 15868394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.
    Rodrigues-Filho R; Campos MM; Ferreira J; Santos AR; Bertelli JA; Calixto JB
    Brain Res; 2004 Aug; 1018(2):159-70. PubMed ID: 15276874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients.
    Pickering G; Pereira B; Morel V; Tiberghien F; Martin E; Marcaillou F; Picard P; Delage N; de Montgazon G; Sorel M; Roux D; Dubray C
    Contemp Clin Trials; 2014 Jul; 38(2):314-20. PubMed ID: 24948402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain.
    Mercadante S; Lodi F; Sapio M; Calligara M; Serretta R
    J Pain Symptom Manage; 1995 Oct; 10(7):564-8. PubMed ID: 8537699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
    Papanas N; Ziegler D
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial.
    Carmland ME; Kreutzfeldt M; Holbech JV; Andersen NT; Jensen TS; Bach FW; Sindrup SH; Finnerup NB
    Trials; 2019 Oct; 20(1):588. PubMed ID: 31604475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.